HIV Rapid Tests: Progress, Perspective, and Future Directions
- 1 March 2003
- journal article
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 7 (2) , 207-8
- https://doi.org/10.1188/03.cjon.207-208
Abstract
In November 2002, the U.S. Food and Drug Administration approved the OraQuick Rapid HIV-1 Antibody Test (OraSure Technologies, Inc., Bethlehem, PA), a reliable, rapid test that detects HIV-1 antibodies. In contrast to other HIV-testing techniques, the OraQuick test uses blood obtained by finger stick instead of venipuncture and provides results in 20 minutes. Implications for practice, as well as future applications of this technology, are discussed in this article.Keywords
This publication has 3 references indexed in Scilit:
- Low Rate of False-Positive Results with Use of A Rapid HIV TestInfection Control & Hospital Epidemiology, 2002
- Ensuring a Public Health Impact of Programs to Reduce HIV Transmission From Mothers to Infants: The Place of Voluntary Counseling and TestingAmerican Journal of Public Health, 2002
- Rapid HIV Testing in Urban Outreach: A Strategy for Improving Posttest Counseling RatesAIDS Education and Prevention, 2001